Journal finder · Scopus Source List Jul. 2026

Cari jurnal Scopus per bidang

Seluruh sumber dalam Scopus Source List, dikelompokkan menurut 27 bidang ASJC dan dipisahkan antara jurnal aktif, tidak aktif, dan dihentikan oleh Scopus — supaya Anda tidak mengirim naskah ke jurnal yang sudah tidak terindeks.

WOS Q1 Q2 Q3 Q4
ABDC A* A B C
AJG 4* 4 3 2 1

Peringkat Web of Science, ABDC, AJG belum tersedia — Scopus Source List tidak memuat kuartil, jadi datanya perlu diimpor terpisah lewat Admin → Scopus (xlsx). Pilihan yang redup di atas belum bisa dipakai.

32.050 sumber

Halaman 386 dari 1.282
SumberISSNPenerbitBidang ASJCPeringkatStatusCakupanOA
Experimental Technology and Management ↗
Journal · ENG
1002-4956 Tsinghua University Press Engineering
Physical Sciences
Q3
SJR 0.210 · h8
Aktif 2021-2026
Experimental Thermal and Fluid Science ↗
Journal · ENG
0894-1777 Elsevier Inc. Chemical Engineering Energy Engineering
Physical Sciences
Q1
SJR 0.706 · h153
Aktif 1988-2026
Experiments in Fluids ↗
Journal · ENG
0723-4864
e 1432-1114
Springer Verlag Chemical Engineering Engineering Physics and Astronomy
Physical Sciences
Q1
SJR 0.724 · h155
Aktif 1983-2026
Expert Opinion on Biological Therapy ↗
Journal · ENG
1471-2598
e 1744-7682
Taylor and Francis Ltd. Biochemistry, Genetics and Molecular Biology Pharmacology, Toxicology and Pharmaceutics
Life Sciences
Q1
SJR 1.045 · h112
Aktif 2001-2026
Expert Opinion on Drug Delivery ↗
Journal · ENG
1742-5247
e 1744-7593
Taylor and Francis Ltd. Pharmacology, Toxicology and Pharmaceutics
Life Sciences
Q1
SJR 1.057 · h152
Aktif 2004-2026
Expert Opinion on Drug Discovery ↗
Journal · ENG
1746-0441
e 1746-045X
Taylor and Francis Ltd. Pharmacology, Toxicology and Pharmaceutics
Life Sciences
Q1
SJR 1.287 · h99
Aktif 2006-2026
Expert Opinion on Drug Metabolism and Toxicology ↗
Journal · ENG
1742-5255
e 1744-7607
Taylor and Francis Ltd. Pharmacology, Toxicology and Pharmaceutics
Life Sciences
Q1
SJR 0.986 · h112
Aktif 2005-2026
Expert Opinion on Drug Safety ↗
Journal · ENG
1474-0338
e 1744-764X
Taylor and Francis Ltd. Medicine
Health Sciences
Q2
SJR 0.860 · h101
Aktif 2002-2026
Expert Opinion on Emerging Drugs ↗
Journal
1472-8214
e 1744-7623
Taylor and Francis Ltd. Medicine Pharmacology, Toxicology and Pharmaceutics
Health Sciences; Life Sciences
Q2
SJR 0.908 · h59
Aktif 2000-2026
Expert Opinion on Investigational Drugs ↗
Journal · ENG
1354-3784
e 1744-7658
Taylor and Francis Ltd. Medicine Pharmacology, Toxicology and Pharmaceutics
Health Sciences; Life Sciences
Q1
SJR 1.199 · h126
Aktif 1994-2026
Expert Opinion on Pharmacotherapy ↗
Journal · ENG
1465-6566
e 1744-7666
Taylor and Francis Ltd. Medicine Pharmacology, Toxicology and Pharmaceutics
Health Sciences; Life Sciences
Q2
SJR 0.765 · h104
Aktif 1999-2026
Expert Opinion on Therapeutic Patents ↗
Journal · ENG
1354-3776
e 1744-7674
Taylor and Francis Ltd. Pharmacology, Toxicology and Pharmaceutics
Life Sciences
Q1
SJR 1.098 · h98
Aktif 1991-2026
Expert Opinion on Therapeutic Targets ↗
Journal · ENG
1472-8222
e 1744-7631
Taylor and Francis Ltd. Biochemistry, Genetics and Molecular Biology Pharmacology, Toxicology and Pharmaceutics
Life Sciences
Q1
SJR 1.383 · h120
Aktif 1997-2026
Expert Review of Anti-Infective Therapy ↗
Journal · ENG
1478-7210
e 1744-8336
Taylor and Francis Ltd. Immunology and Microbiology Medicine
Health Sciences; Life Sciences
Q1
SJR 1.024 · h110
Aktif 2003-2026
Expert Review of Anticancer Therapy ↗
Journal · ENG
1473-7140
e 1744-8328
Taylor and Francis Ltd. Medicine
Health Sciences
Q2
SJR 0.840 · h91
Aktif 2001-2026
Expert Review of Cardiovascular Therapy ↗
Journal · ENG
1477-9072
e 1744-8344
Taylor and Francis Ltd. Medicine
Health Sciences
Q2
SJR 0.655 · h68
Aktif 2003-2026
Expert Review of Clinical Immunology ↗
Journal · ENG
1744-666X
e 1744-8409
Taylor and Francis Ltd. Immunology and Microbiology Medicine
Health Sciences; Life Sciences
Q2
SJR 1.198 · h85
Aktif 2006-2026
Expert Review of Clinical Pharmacology ↗
Journal · ENG
1751-2433
e 1751-2441
Taylor and Francis Ltd. Medicine Pharmacology, Toxicology and Pharmaceutics
Health Sciences; Life Sciences
Q1
SJR 0.848 · h73
Aktif 2008-2026
Expert Review of Endocrinology and Metabolism ↗
Journal · ENG
1744-6651
e 1744-8417
Taylor and Francis Ltd. Medicine
Health Sciences
Q2
SJR 1.107 · h41
Aktif 2006-2026
Expert Review of Gastroenterology and Hepatology ↗
Journal · ENG
1747-4124
e 1747-4132
Taylor and Francis Ltd. Medicine
Health Sciences
Q2
SJR 0.878 · h78
Aktif 2007-2026
Expert Review of Hematology ↗
Journal · ENG
1747-4086
e 1747-4094
Taylor and Francis Ltd. Medicine
Health Sciences
Q2
SJR 0.702 · h61
Aktif 2008-2026
Expert Review of Medical Devices ↗
Journal · ENG
1743-4440
e 1745-2422
Taylor and Francis Ltd. Engineering Medicine
Health Sciences; Physical Sciences
Q2
SJR 0.548 · h88
Aktif 2004-2026
Expert Review of Molecular Diagnostics ↗
Journal · ENG
1473-7159
e 1744-8352
Taylor and Francis Ltd. Biochemistry, Genetics and Molecular Biology Medicine
Health Sciences; Life Sciences
Q1
SJR 1.031 · h95
Aktif 2001-2026
Expert Review of Neurotherapeutics ↗
Journal · ENG
1473-7175
e 1744-8360
Taylor and Francis Ltd. Medicine Neuroscience
Health Sciences; Life Sciences
Q1
SJR 1.106 · h110
Aktif 2001-2026
Expert Review of Ophthalmology ↗
Journal · ENG
1746-9899
e 1746-9902
Taylor and Francis Ltd. Engineering Medicine Health Professions
Health Sciences; Physical Sciences
Q3
SJR 0.314 · h34
Aktif 2006-2026

Sumber: Scopus Source List Jul. 2026, diperbarui 2026-09-07 07:05. Kuartil Q1–Q4, SJR, dan h-index berasal dari SCImago Journal Rank; sumber tanpa data kuartil biasanya baru terindeks atau bukan jurnal. Tautan judul membuka halaman sumber di Scopus.